Frederick L. Ferris - Concepedia

Author

Frederick L. Ferris

Also Known As

Age-Related Eye Disease Study Research Group, Barbra Blodi, Emily Chew, F Ferris, F L Ferris, F. Ferris, F. L. Ferris, F.L. Ferris, FREDERICK L FERRIS, FREDERICK L. FERRIS

325

Publications

41.6K

Citations

H-Index

118

Concepts

All Affiliations

National Eye Institute National Institutes of Health Emmes (United States)Johns Hopkins University Jaeb Center for Health Research

About

Frederick L. Ferris is an author at National Eye Institute specializing in ophthalmology, medicine, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	51	82	14.2K
2	Public Health	14	14	2.1K
3	Health Sciences	7	9	664
4	Social Sciences	3	3	324
5	Engineering	2	2	72

Frederick L. Ferris

159

Publications

31.8K

Citations

H-Index

Page 1

	Year	Citations
Complement Factor H Polymorphism in Age-Related Macular Degeneration Robert J. Klein, Caroline J. Zeiss, Emily Y. Chew, Science	2005	4.5K
New Visual Acuity Charts for Clinical Research Frederick L. Ferris, Aaron Kassoff, George H. Bresnick, American Journal of Ophthalmology Physiological OpticOphthalmologyEye TrackingVisual ImpairmentVisual Function	1982	2.1K
Clinical Classification of Age-related Macular Degeneration Frederick L. Ferris, Charles P. Wilkinson, Alan C. Bird, Ophthalmology Age-related DiseasesOcular DiseaseOphthalmologyClinical Classification	2013	1.7K
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration Daniel Martín, Maureen G. Maguire, Stuart L. Fine, Ophthalmology Ocular DiseaseOphthalmologyAge-related DiseasesEye HealthGlaucoma	2012	1.7K
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema Michael J. Elman, Lloyd Paul Aiello, Roy W. Beck, Ophthalmology Diabetic RetinopathyOcular DiseaseVitreous BodyOphthalmologyDeferred Laser	2010	1.4K
Retinopathy in Diabetes Donald S. Fong, Lloyd Paul Aiello, Thomas W. Gardner, Diabetes Care Type 1Diabetic RetinopathyOcular DiseaseOphthalmologyDiabetes	2004	1.1K
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema John A. Wells, Adam R. Glassman, Allison R. Ayala, Ophthalmology Diabetic RetinopathyOcular DiseaseOphthalmologyDiabetesDiabetic Macular Edema	2016	982
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol, JAMA	2015	743
Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration Maureen G. Maguire, Daniel Martín, Gui‐Shuang Ying, Ophthalmology Five-year OutcomesOcular DiseaseCardiovascular DiseaseOphthalmologyAge-related Diseases	2016	683
Risk Factors for the Incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS)AREDS report no. 19 Traci E Clemons, Roy C. Milton, Ronald Klein, Ophthalmology Ocular DiseaseOphthalmologyAge-related DiseasesAreds ReportEye Health	2005	676

Page 1